{"downloaded": true, "htmlmade": false, "full": {"id": "30149462", "source": "MED", "pmid": "30149462", "pmcid": "PMC6218140", "fullTextIdList": {"fullTextId": "PMC6218140"}, "doi": "10.3233/jpd-181353", "title": "Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.", "authorString": "Li H, Jiang H, Zhang B, Feng J.", "authorList": {"author": [{"fullName": "Li H", "firstName": "Hong", "lastName": "Li", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA."}, {"affiliation": "Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY, USA."}]}}, {"fullName": "Jiang H", "firstName": "Houbo", "lastName": "Jiang", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA."}, {"affiliation": "Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY, USA."}]}}, {"fullName": "Zhang B", "firstName": "Boyang", "lastName": "Zhang", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA."}, {"affiliation": "Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY, USA."}]}}, {"fullName": "Feng J", "firstName": "Jian", "lastName": "Feng", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA."}, {"affiliation": "Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY, USA."}]}}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"issue": "4", "volume": "8", "journalIssueId": "2741110", "dateOfPublication": "2018", "monthOfPublication": "0", "yearOfPublication": "2018", "printPublicationDate": "2018-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2018", "pageInfo": "479-493", "abstractText": "Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of cases are idiopathic, without a clear etiology, mutations in many genes have been linked to rare, familial forms of PD. It has been quite challenging to develop effective animal models of PD that capture salient features of PD. The discovery of induced pluripotent stem cells (iPSCs) makes it possible to generate patient-specific DA neurons to study PD. Here, we review the methods for the generation of iPSCs and discuss previous studies using iPSC-derived neurons from monogenic forms of PD. These investigations have revealed several converging pathways that intersect with the unique vulnerabilities of human nigral DA neurons. With the rapid development in stem cell biology, it is possible to generate patient-specific neurons that will be increasingly similar to those in the brain of the patient. Combined with the ability to edit the genome to generate isogenic iPSCs, the generation and analysis of patient-specific midbrain DA neurons will transform PD research by providing a valuable tool for mechanistic study and drug discovery.", "affiliation": "Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Research Support, U.S. Gov't, Non-P.H.S.", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"grantId": "I01 BX002452", "agency": "BLRD VA", "acronym": "BX", "orderIn": "0"}, {"grantId": "R56 NS102148", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}, {"grantId": "I01 BX003831", "agency": "BLRD VA", "acronym": "BX", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Substantia Nigra", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Parkinson Disease", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Ubiquitin-Protein Ligases", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Models, Biological"}, {"majorTopic_YN": "N", "descriptorName": "alpha-Synuclein", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Induced Pluripotent Stem Cells", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Dopaminergic Neurons", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "Y"}]}}]}, "keywordList": {"keyword": ["Dopaminergic neurons", "Parkin", "\u03b1-synuclein", "DJ-1", "Stem Cells", "Lrrk2", "Pink1", "Pluripotent", "Ipsc", "Gba"]}, "chemicalList": {"chemical": [{"name": "alpha-Synuclein", "registryNumber": "0"}, {"name": "Ubiquitin-Protein Ligases", "registryNumber": "EC 2.3.2.27"}, {"name": "parkin protein", "registryNumber": "EC 2.3.2.27"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-181353"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6218140"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6218140?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "14", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-10-17", "dateOfCreation": "2018-08-29", "firstIndexDate": "2018-08-28", "fullTextReceivedDate": "2020-07-09", "dateOfRevision": "2019-10-17", "firstPublicationDate": "2018-01-01"}, "htmllinks": "https://europepmc.org/articles/PMC6218140", "abstract": "Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of cases are idiopathic, without a clear etiology, mutations in many genes have been linked to rare, familial forms of PD. It has been quite challenging to develop effective animal models of PD that capture salient features of PD. The discovery of induced pluripotent stem cells (iPSCs) makes it possible to generate patient-specific DA neurons to study PD. Here, we review the methods for the generation of iPSCs and discuss previous studies using iPSC-derived neurons from monogenic forms of PD. These investigations have revealed several converging pathways that intersect with the unique vulnerabilities of human nigral DA neurons. With the rapid development in stem cell biology, it is possible to generate patient-specific neurons that will be increasingly similar to those in the brain of the patient. Combined with the ability to edit the genome to generate isogenic iPSCs, the generation and analysis of patient-specific midbrain DA neurons will transform PD research by providing a valuable tool for mechanistic study and drug discovery.", "Keywords": ["Dopaminergic neurons", "Parkin", "\u03b1-synuclein", "DJ-1", "Stem Cells", "Lrrk2", "Pink1", "Pluripotent", "Ipsc", "Gba"], "pdflinks": "https://europepmc.org/articles/PMC6218140?pdf=render", "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Li H", "Jiang H", "Zhang B", "Feng J"], "title": "Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells."}